Evidence map›Paper›PMID 35112227›Full record

ArticlePharmaceutical research2022

Differences in Cerebral Distribution between Imipramine and Paroxetine via Membrane Transporters at the Rat Blood-Brain Barrier.

Shin-Ichi Akanuma, Myeongrae Han, Yuka Murayama, Yoshiyuki Kubo, Ken-Ichi Hosoya

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shin-Ichi Akanuma *Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. akanumas@pha.u-toyama.ac.jp.
Myeongrae Han *Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Yuka Murayama *Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Yoshiyuki KuboDepartment of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Ken-Ichi HosoyaDepartment of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. hosoyak@pha.u-toyama.ac.jp.ORCID http://orcid.org/0000-0001-5633-3865
University of Toyama · JP

Funding

Japan Society for the Promotion of Science JP19K07160Japan Society for the Promotion of Science JP20H03403Smoking Research Foundation n/a
6 · The paper itself

Abstract

purposeThe present study aimed to elucidate the transport properties of imipramine and paroxetine, which are the antidepressants, across the blood-brain barrier (BBB) in rats.

methodsIn vivo influx and efflux transport of imipramine and paroxetine across the BBB were tested using integration plot analysis and a combination of brain efflux index and brain slice uptake studies, respectively. Conditionally immortalized rat brain capillary endothelial cells, TR-BBB13 cells, were utilized to characterize imipramine and paroxetine transport at the BBB in vitro.

resultsThe in vivo influx clearance of [

conclusionsOur study showed the comprehensive outcomes of imipramine and paroxetine transport at the BBB, implying that molecular mechanism(s) distinct from previously reported transporters and transport systems are involved in the transport.

Indexed as

AnimalsAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicBiological TransportBlood-Brain BarrierCell LineImipramineInjections, IntravenousKineticsMaleMembrane Transport ProteinsModels, BiologicalParoxetinePermeabilityRatsRats, WistarAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicImipramineMembrane Transport ProteinsParoxetineblood-brain barriercationic drug transportimipraminelysosomal sequestrationparoxetine

Identifiers

PMID35112227
OpenAlexW4210721140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.